Search Results for "poverty guidelines"
Displaying 1 - 20 of 503 results. 20 results shown per page. Page 1 of 26.
Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines
Publication Date
In April 2021 the U.S. Department of Health and Human Services (HHS) issued revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (Practice Guideline).
HHS Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility, and Integrity of Information Disseminated to the Public
Publication Date
This site describes the HHS Information Quality Guidelines as well as the supporting administrative mechanisms to request correction of information covered under the guidelines. The HHS Guidelines were developed in accordance with the provisions of P.L.
State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2022 American Community Survey
Publication Date
State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2022 American Community SurveyMethodological Description
A Historical View of The Demographic and Employment Characteristics of Families Receiving Child Care Subsidies From 2009-2013
Publication Date
The child care subsidy program provides critical support to families to support parental labor force participation as well as child development. This study provides a historical view of the socioeconomic and demographic characteristics of parents who received subsidies over the 2009-2013 period.
Participation in the U.S. Social Safety Net: Multiple Programs, 2019
Publication Date
Safety net programs provide critical support to people during times of economic hardship. Yet the reach and coverage of the safety net, particularly in times of increased need and among economically disadvantaged groups, is not well understood. The U.S.
Guidelines for Ensuring the Quality of Information Disseminated to the Public
Publication Date
Agency Contacts for Information Correction Requests Administration for Children and Families (ACF) Administration for Children and Families 370 L'Enfant Promenade SW Aerospace Building Washington, D.C. 20447 URL: FAQ ACF
Evaluation & Evidence
Publication Date
Evaluation and analysis provide essential evidence for HHS to understand how its programs work, for whom, and under what circumstances. HHS builds evidence through evaluation and analysis in order to inform decisions in budget, legislative, regulatory, strategic planning, program, and policy arenas.
CDC — Fluoridation: Request for Correction (RFC)
Publication Date
From: To: InfoQuality@cdc.gov Date: Tue, 19 Nov 2002 Subject: information quality request for correction of influential scientific information
CDC — Gonorrhea Link: Request for Correction (RFC)
Publication Date
Requestor: Organizational Affiliation: Contractor, Division of STD Prevention Type of Disseminated Information: Website Date of request: 1/8/2003 Description of Information:
CDC — Fluoroquinolone: Request for Reconsideration (RFR)
Publication Date
March 27, 2003 VIA FEDEX and E-MAIL (w/o Attachments) CDC/ATSDR MASO/MS-E11 1600 Clifton Road, N.E. Atlanta, GA 30333 Information Quality Appeal
CDC — Fluoroquinolone: HHS Response to Rfc
Publication Date
March 13, 2003 Kent D. McClure, DVM, JD General Counsel Animal Health Institute 1325 G. Street, NW, Ste. 700 Washington, DC 20005-3104
CDC — Fluoroquinolone: Request for Correction (RFC)
Publication Date
Requestor: Kent McClure Organizational Affiliation: Animal Health Institute Date of request: 12/13/2002 Description of Information:
FDA — Campylobacter Risk Assessment: HHS Response to Rfc
Publication Date
March 22, 2003 Kent D. McClure, DVM, JD General Counsel Animal Health Institute 1325 G Street, NW, Suite 700 Washington, D.C. 20005-3104 Dear Dr. McClure:
FDA — Campylobacter Risk Assessment: HHS Response to Rfr
Publication Date
September 16, 2003 Kent D. McClure, D.V.M., J.D. General Counsel Animal Health Institute1324 G Street, N.W. Suite 700Washington, D.C. 20005 Re: Appeal of Request for Correction of Information Dear Dr. McClure:
FDA — Campylobacter Risk Assessment: Request for Reconsideration (RFR)
Publication Date
April 16, 2003 VIA HAND DELIVERY and E-MAIL (w/o Attachments) Office of the Ombudsman Food and Drug Administration 5600 Fishers Lane Room 14B03, HF-7 Rockville, MD 20857 Re: INFORMATION QUALITY APPEAL Dear Sir/Madame:
CMS — SafeBlood: Interim Response, January 14, 2003
Publication Date
January 14, 2003 Debby Thetford Nye, Esq. Mitchell, Williams, Selig, Gates, and Woodward, P.L.L.C. 5414 Pinnacle Point Drive, Suite 500 Rogers, Arkansas 72758-8131 Dear Ms. Nye:
CMS — SafeBlood: Request for Correction (RFC)
Publication Date
November 14, 2002. BEFORE THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICESCENTERS FOR MEDICARE AND MEDICAID SERVICES INFORMATION QUALITY REQUEST FOR CORRECTION OF CERTAINDISSEMINATED INFORMATION
NTP — Anthraquinone Abstract: HHS Response to Rfr
Publication Date
September 8, 2003 Mr. Jerry A. Cook Technical Director Chemical Products Corporation Cartersville, Georgia 30120 Re: Request for Reconsideration submitted March 27, 2003 Dear Mr. Cook:
CMS — Safeblood: HHS Response to Rfc
Publication Date
April 17, 2003 Debbie Thetford Nye Mitchell, Williams, Selig, Gates, and Woodward, P.L.L.C. 5414 Pinnacle Point Drive, Suite 500 Rogers, Arkansas 72758-8131 Dear Ms. Nye:
CMS — SafeBlood: Interim Response, February 13, 2003
Publication Date
February 13, 2003 Debby Thetford Nye, Esq. Mitchell, Williams, Selig, Gates, and Woodward, P.L.L.C. 5414 Pinnacle Point Drive, Suite 500 Rogers, Arkansas 72758-8131 Dear Ms. Nye: